CLINICAL_TRIALS
trial_result
· 2021-12-17
Clinical Trial Update: Trial of Rifaximin in Probable Alzheimer's Disease [Phase 2]
Summary
Phase 2 trial of rifaximin in probable Alzheimer's disease has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-12-17